The purpose of this proposal is to launch the independent research career of an interventional cardiologist who wishes to focus on identifying novel molecular mechanisms underlying arterial repair and atherosclerosis. The overall scientific aim is to provide important insights towards deriving targeted strategies to fight cardiovascular disease. To achieve this, the Candidate will couple training in a range of molecular and cell profiling techniques with a structured program of career developmental activities. The Candidate will be supervised by a dedicated team of mentors and advisors who will oversee the proposed research project and career development program. There has been a paucity of significant breakthroughs in our understanding of vascular disease and atherosclerosis in recent years. While incremental progress has been made, the field continues to search in earnest for ways to stabilize atherosclerotic plaques and reduce cardiovascular disease. Given that atherothrombosis remains the #1 killer in Western society, this is an urgent and unmet clinical need. Founded upon on compelling preliminary data, this proposal is a two-pronged systematic approach to address this problem. The role of the endothelium and of endothelial to mesenchymal cell transition in normal vascular biology and atherosclerosis is the focal point of this proposal.
In Specific Aim 1, using unique mouse models to track endothelial cells as they migrate and even change their phenotype, the Candidate will characterize key cell types and identify new molecular pathways responsible for endothelial homeostasis and repair. These are critical questions to address, as the failure to properly repair the endothelium leads to arterial thrombosis, vascular occlusion and tissue death.
In Specific Aim 2, focused and detailed experiments will explore the cellular and molecular processes that underpin atherosclerosis. Specifically, the Candidate will investigate the ability of endothelial cells to switch their celluar phenotype to become smooth muscle cells, fibroblasts or other cells that drive atherosclerosis. This project will define the extent of this 'cell switching'and will unlock ways to manipulate thi process with the goal of developing novel and more efficacious treatment options. In addition, these experiments will be used to train the Candidate in the techniques of laser-capture microdissection, gene chip analysis, flow cytometry and the use of viral vectors. This program will serve as the seed for future molecular studies and also for potential pre-clinical and ultimately clinical studies targeting atherosclerosis and vascular disease. The relevance of this project to clinical medicine and society is significant. Here, we will investigate the cellular and molecular mechanisms dictating cardiovascular morbidity and mortality, with a view to making meaningful inroads into the prevention and treatment of this epidemic.

Public Health Relevance

This proposal seeks to characterize the contribution of endothelial cells to arterial homeostasis, arterial repair and atherosclerosis. Using unique mouse models we will define the function of endothelial cells in these processes and also investigate the ability of endothelial cells to change their phenotype to become smooth muscle cells, fibroblasts or other cells that drive atherosclerosis. These experiments are highly relevant to public health as they are designed to identify novel molecular pathways, with the ultimate aim of creating new treatments to fight cardiovascular disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL111330-03
Application #
8586555
Study Section
Special Emphasis Panel (ZHL1-CSR-K (O1))
Program Officer
Wang, Wayne C
Project Start
2011-12-12
Project End
2016-11-30
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
3
Fiscal Year
2014
Total Cost
$129,465
Indirect Cost
$9,590
Name
Icahn School of Medicine at Mount Sinai
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Tomey, Matthew I; Narula, Jagat; Kovacic, Jason C (2014) Advances in the understanding of plaque composition and treatment options: year in review. J Am Coll Cardiol 63:1604-16
Lipskaia, Larissa; Bobe, Regis; Chen, Jiqiu et al. (2014) Synergistic role of protein phosphatase inhibitor 1 and sarco/endoplasmic reticulum Ca2+ -ATPase in the acquisition of the contractile phenotype of arterial smooth muscle cells. Circulation 129:773-85
Michelis, Katherine C; Olin, Jeffrey W; Kadian-Dodov, Daniella et al. (2014) Coronary artery manifestations of fibromuscular dysplasia. J Am Coll Cardiol 64:1033-46
Dangas, George D; Maehara, Akiko; Evrard, Solene M et al. (2014) Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study. Eur Heart J Cardiovasc Imaging 15:201-9
Garcia-Garcia, Hector M; Jang, Ik-Kyung; Serruys, Patrick W et al. (2014) Imaging plaques to predict and better manage patients with acute coronary events. Circ Res 114:1904-17
Fuster, Valentin; Kovacic, Jason C (2014) Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatment. Circ Res 114:1847-51
Cooley, Brian C; Nevado, Jose; Mellad, Jason et al. (2014) TGF-? signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med 6:227ra34
Michelis, Katherine C; Boehm, Manfred; Kovacic, Jason C (2014) New vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature. Stem Cell Res 13:666-82
Chaanine, A H; Nonnenmacher, M; Kohlbrenner, E et al. (2014) Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure. Gene Ther 21:379-86
Kherada, Nisharahmed I; Sartori, Samantha; Tomey, Matthew I et al. (2014) Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study. Int J Cardiol 174:13-7

Showing the most recent 10 out of 23 publications